###begin article-title 0
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
###end article-title 0
###begin p 1
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 491 496 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 535 540 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 632 637 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 638 643 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 704 709 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 725 730 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
Brca1 is involved in multiple biological pathways including DNA damage repair, transcriptional regulation, and cell-cycle progression. A complex pattern of interactions of Brca1 with Trp53 has also emerged. Xu and coworkers found that haploid loss of Trp53 significantly reduces the embryonic lethality observed in mice with a homozygous in-frame deletion of Brca1 exon 11. They report that widespread apoptosis correlates with the embryonic lethality resulting from this homozygous Delta11 Brca1 mutation. A mechanism responsible for Brca1-associated carcinogenesis is proposed. These experiments extend our knowledge of a complex Brca1/Trp53 relationship. However, the precise mechanisms through which Brca1 interacts with Trp53 to suppress mammary tumor formation have yet to be elucidated.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 349 350 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
Brca1 appears to have a role in multiple complex biological pathways including DNA damage repair, transcriptional regulation, and cell-cycle checkpoint control. Brca1 is thought to function as a caretaker that is responsible for maintaining genomic integrity [1]. Loss of Brca1 function has been shown to lead to defective DNA repair, to defective G2-M cell-cycle checkpoints, to increased apoptosis, and to genomic instability. This generalized genetic instability is thought to lead to the accumulation of additional mutations that eventually allow Brca1-deficient cells to undergo neoplastic transformation (reviewed in [2]). Perhaps the most intriguing role of Brca1, however, is its complex interaction with Trp53.
###end p 3
###begin p 4
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21</italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 534 539 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 540 546 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1a</italic>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
The recent study by Xu et al. attempts to clarify our understanding of the complicated Trp53/Brca1 relationship [3]. Substantial evidence suggests that Brca1 and Trp53 appear to be linked in their roles as tumor suppressor genes. Brca1 and Trp53 are coordinately regulated in their gene expression [4]. Brca1 physically associates with Trp53 and stimulates its transcriptional activity [5,6]. The Trp53 protein appears to regulate Brca1 expression levels [7], while Brca1 in turn upregulates p21[8]. Brca1 loss therefore triggers the Trp53-Cdkn1a-mediated cell-cycle checkpoint and corresponding cell death [9]. Finally, Trp53 loss appears to enhance Brca1-linked tumorigenesis [10-12].
###end p 4
###begin title 5
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
Trp53 rescue of Brca1 embryonic lethality
###end title 5
###begin p 6
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1a</italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 360 375 360 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 392 397 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 397 412 389 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 471 476 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 561 566 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 566 581 550 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 581 586 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 586 589 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 695 700 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 703 704 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 730 735 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 740 745 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1024 1029 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 1034 1039 1010 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1226 1231 1202 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 1236 1241 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
The specific role of Trp53 in rescue of embryonic lethality of mice with various Brca1 mutations remains unclear. Earlier studies have shown that Trp53 and Cdkn1a deficiencies can extend the development of several severe Brca1 mutations [13-15]. Xu et al.[3] found that haploid loss of Trp53 significantly rescues the embryonic lethality resulting from a Brca1Delta11/Delta11 mutation. These Brca1Delta11/Delta11 embryos normally die during late gestation in a wild-type Trp53 background. With p53 haploinsufficiency, however, approximately 80% of the expected Brca1Delta11/Delta11Trp53+/- mice survive based on Mendelian ratios for offspring from a double heterozygous cross. Unfortunately, Xu et al. [3] failed to note that the Brca1 and Trp53 loci reside within 20 cM of each other on mouse chromosome 11. These loci are therefore closely linked and do not recombine independently, as they would if located on different chromosomes. To determine the predicted genotypic distribution of offspring, the phase of the mutant Brca1 and Trp53 alleles on the parental chromosomes used in this intercross must be known. The expected numbers of specific genotypes in the offspring will differ widely depending on whether the mutant Brca1 and Trp53 alleles were present in cis versus trans configurations in the parental chromosomes.
###end p 6
###begin p 7
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 194 199 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 218 224 214 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 225 227 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 279 284 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 291 296 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 447 452 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 500 505 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 677 682 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca2</italic>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 695 697 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
Two other groups have described mice with related hypo-morphic mutant Brca1 alleles that remove all or part of exon 11 while preserving the Delta11 exon splice variant that produces a truncated Brca1 protein. Cressman et al.[16] described three mice homozygous for both a mutant Trp53 and a Brca1 alteration that normally results in late embryonic lethality in the homozygous state. These authors propose that other genetic factors in addition to Trp53 loss may be required for the survival of these Brca1-mutant mice. It is interesting to speculate that DBA/2-specific alleles may be involved since the DBA/2 genetic background also appears to enhance survival of hypomorphic Brca2 mutants [17,18].
###end p 7
###begin p 8
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 679 684 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 711 716 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 913 918 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 1053 1059 1049 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1095 1100 1091 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 1139 1144 1135 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1324 1329 1320 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1223 1227 <span type="species:ncbi:10090">mice</span>
Ludwig et al. have generated mice with a related hypomorphic Brca1 mutation [19], which was viable in particular genetic backgrounds in the absence of any additional Trp53 mutation. This exon 11 mutation was predicted to lead to the truncation of the Brca1 protein after the first 924 amino acids. This mutant Brca1 protein is unique since it retains the nuclear localization signals in exon 11 as well as a proposed Trp53 interaction domain between residues 224 and 500 [2,5]. However, a Delta11 splice variant protein is also still expressed in these mice as with mutants from the other groups. From original intercrosses between 129/Sv x C57BL/6J heterozygous parents, Ludwig et al. found only 4% homozygous Brca1 mutants compared with the expected 25%. After backcrossing with 129/Sv mice or outcrossing to the MF1 strain, however, these investigators reported complete restoration of Mendelian ratios. These Brca1 mutant mice thus appeared to have a more complete rescue of embryonic lethality based on genetic background differences alone than Xu et al. were able to obtain by introducing Trp53 haploinsufficiency. Unfortunately, Xu et al. did not provide any information about the genetic background of their mutant mice. This dramatic difference in explanations for the embryonic lethality 'rescue' of these similar Brca1 mutations is difficult to reconcile.
###end p 8
###begin p 9
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 358 359 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 678 693 678 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 792 795 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bax</italic>
###xml 799 805 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1a</italic>
Xu et al. state that a major finding of the study was the ability to demonstrate the widespread apoptosis of Brca1-deficient embryos and the lack of this apoptosis in the Brca1 mutants with Trp53 mutations [3]. They propose that the apoptotic process normally triggered by Brca1 loss does not occur with Trp53 haploinsufficiency due to loss of the critical G1-S checkpoint control. Cells with Brca1 mutations that have accumulated DNA damage are therefore allowed to proliferate rather than undergo apoptosis. Xu et al. suggest this difference in apoptosis is a plausible explanation for the rescue of the embryonic lethality of these Brca1 mutants. However, the rescue of Brca1Delta11/Delta11 embryos did not occur when single downstream pathways of p53 were disrupted by eliminating either Bax or Cdkn1a.
###end p 9
###begin title 10
###xml 48 59 48 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53/Brca1</italic>
Mammary tumorigenesis association with combined Trp53/Brca1 deficiency
###end title 10
###begin p 11
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 238 253 238 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 274 279 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 341 346 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 384 390 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 391 393 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 431 436 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 553 558 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 584 589 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
Multiple studies have now suggested that Trp53 loss accelerates mammary tumor formation when associated with Brca1 mutations. Although quantitative data was not presented in this report, Xu et al. [3] state that most of their female Brca1Delta11/Delta11 mice that carried a Trp53 mutation developed mammary tumors with loss of the remaining Trp53 allele by 6-12 months of age. Ludwig et al.[13] found that many of their homozygous Brca1-mutant mice also developed mammary tumors as well as a wide variety of other tumors. They also investigated whether Trp53 deficiency affected this Brca1-associated tumorigenesis, and observed accelerated tumorigenesis in mice carrying both mutations.
###end p 11
###begin p 12
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 554 559 <span type="species:ncbi:9606">human</span>
Trp53 hemizygosity allowed mice with the Brca1 mutation developed by Cressman et al. [11] to develop a few mammary tumors after exposure to ionizing radiation, although these results did not achieve statistical significance. In contrast, mice with this Brca1 mutation on a wild-type Trp53 background did not develop mammary tumors. Finally, there was a decreased latency and increased incidence of mammary tumor formation in conditionally mutant Brca1 mice that had a Trp53 mutation [12,20]. A high frequency of Trp53 mutations has also been observed in human BRCA-linked tumors. Some of these Trp53 mutations are unique or unusual, suggesting that the tumorigenesis pathway mediated by combined Brca1/Trp53 mutations may be different to the pathway for other Trp53-mediated tumorigenesis, such as what is observed in Li-Fraumini syndrome [21,22].
###end p 12
###begin title 13
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53/Brca1</italic>
Biological pathway of the Trp53/Brca1 interaction
###end title 13
###begin p 14
###xml 3 9 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 136 151 136 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 158 159 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 162 167 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 213 218 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 218 233 210 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 307 311 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mdm2</italic>
###xml 352 357 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 387 392 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 392 407 372 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 492 497 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 517 522 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 565 570 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 726 731 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 763 768 735 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Xu et al. attempted to further elucidate the molecular interaction between Trp53 and Brca1 that might lead to tumorigenesis in the Brca1Delta11/Delta11 mice [3]. Trp53 was found to have decreased stability in the Brca1Delta11/Delta11 background after treatment with exogenous DNA damaging agents. Increased Mdm2 levels and decreased phosphorylation of Trp53 at Ser18 in gamma-irradiated Brca1Delta11/Delta11 mutant cells were suggested to be the primary causes for the decreased stability of Trp53 in these cells. Xu et al. propose that this decreased stability of Trp53 after stress-induced DNA damage might allow additional mutations to accumulate. Ultimately, such genetic alterations may allow the proliferation defect of Brca1 deficiency to be overcome, and Brca1-associated tumorigenesis will result.
###end p 14
###begin title 15
Conclusions
###end title 15
###begin p 16
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
Although the report by Xu et al. has contributed to our understanding of the Brca1/Trp53 relationship, a number of key questions remain to be addressed.
###end p 16
###begin title 17
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
Why a rescue of Brca1-deficient embryonic lethality with Trp53?
###end title 17
###begin p 18
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 79 94 79 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 124 129 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 216 221 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 269 274 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 303 308 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 396 398 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 399 401 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 431 436 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 436 451 428 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;11/&#916;11</sup>
###xml 520 525 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 572 577 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 622 627 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 665 670 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
The authors propose the substantial difference found in apoptosis between Brca1Delta11/Delta11 mutant cells with or without Trp53 mutations is a logical explanation for the rescue of the embryonic lethality of these Brca1 mutants. However, several studies suggest that Brca1 mutant embryos in which the Trp53-mediated apoptotic pathway is intact do not necessarily have an increase in apoptosis [14,16]. In addition, the rescue of Brca1Delta11/Delta11 embryos did not occur when disrupting single downstream pathways of Trp53. This suggests that the process through which Trp53 might allow for an extension of survival of Brca1 mutants must involve either multiple Trp53-mediated pathways or additional genetic pathways altogether.
###end p 18
###begin title 19
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
What is the relationship between BRCA1 and Trp53 mutations that leads specifically to mammary tumor development?
###end title 19
###begin p 20
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
The basis for the tissue specificity for Brca1/Trp53 tumorigenesis remains unknown. It is interesting that the incidence of mammary tumors in Trp53-deficient mice appears to be dependent on genetic background strain [23]. This suggests that different sets of modifier loci in different inbred strains of mice impact the effect of the loss of Trp53 in specific cell types or tissues. Other studies have shown that the type of tumor resulting from Trp53 loss can differ dramatically depending on the tissue type and the oncogenic pathway involved [2]. In mammary tumorigenesis, it has been suggested that BRCA1 and Trp53 deficiencies cooperate only with exposure of the mammary gland to DNA damage [11]. Alternatively, a lack of downstream mediators in tissues other than ovarian and mammary glands has been suggested to explain the tissue-specificity of Brca1-associated tumorigenesis [2].
###end p 20
###begin title 21
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
Are the molecular mechanisms for the Trp53 rescue of Brca1 embryonic lethality and the Trp53-mediated acceleration of Brca1-induced mammary tumorigenesis the same?
###end title 21
###begin p 22
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trp53</italic>
Even if one assumes that Trp53-mediated apoptosis is significantly relevant for the mechanism of Trp53 rescue of Brca1 lethality, it is unclear how this Trp53 mechanism relates to tumorigenesis due to Trp53 loss. Although some studies clearly demonstrate the association of loss of Trp53 with loss of apoptosis in developing tumors, other studies do not find this correlation, suggesting that p53 loss might alter tumor progression by different mechanisms in different cell types or tumor pathways [24,25]. In fact, some evidence suggests that the multiple functions of Trp53 as a tumor suppressor, apoptosis inducer, and cell-cycle regulator may be entirely independent from each other [26]. Future directions to begin to establish the downstream partners and pathways involved in Brca1/Trp53 tumorigenesis will clearly be necessary to answer these questions.
###end p 22
###begin title 23
Acknowledgements
###end title 23
###begin p 24
The authors thank Dr Cynthia Afshari and Dr Deborah Swope for the critical review of this manuscript.
###end p 24
###begin article-title 25
###xml 29 40 <span type="species:ncbi:111938">Gatekeepers</span>
Cancer-susceptibility genes. Gatekeepers and caretakers.
###end article-title 25
###begin article-title 26
Roles of BRCA1 and its interacting proteins.
###end article-title 26
###begin article-title 27
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle, and tumorigenesis.
###end article-title 27
###begin article-title 28
BRCA1 regulates p53-dependent gene expression.
###end article-title 28
###begin article-title 29
BRCA1 physically associates with p53 and stimulates its transcriptional activity.
###end article-title 29
###begin article-title 30
The second BRCT domain of BRCA1 protein interacts with p53 and stimulates transcription from the p21(WAF1/CIP1) promoter.
###end article-title 30
###begin article-title 31
###xml 44 49 <span type="species:ncbi:9606">human</span>
Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
###end article-title 31
###begin article-title 32
Repression of BRCA1 through a feedback loop involving p53.
###end article-title 32
###begin article-title 33
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
###end article-title 33
###begin article-title 34
TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: Distinctive spectrum and structural distribution.
###end article-title 34
###begin article-title 35
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Mammary tumor formation in p53- and BRCA1-deficient mice.
###end article-title 35
###begin article-title 36
Conditional mutant of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
###end article-title 36
###begin article-title 37
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.
###end article-title 37
###begin article-title 38
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.
###end article-title 38
###begin article-title 39
Partial rescue of Brca1(5-6) early embryonic lethality by p53 or p21 null mutation.
###end article-title 39
###begin article-title 40
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.
###end article-title 40
###begin article-title 41
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca2</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
###end article-title 41
###begin article-title 42
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca2</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Thymic lymphomas in mice with a truncating mutation in Brca2.
###end article-title 42
###begin article-title 43
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brca1</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Tumorigenesis in mice carrying a truncating Brca1 mutation.
###end article-title 43
###begin article-title 44
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
###end article-title 44
###begin article-title 45
P53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
###end article-title 45
###begin article-title 46
Novel p53 mutations selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.
###end article-title 46
###begin article-title 47
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
###end article-title 47
###begin article-title 48
###xml 0 72 0 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53-dependent apoptosis suppresses tumor growth and progression in vivo.</italic>
p53-dependent apoptosis suppresses tumor growth and progression in vivo.
###end article-title 48
###begin article-title 49
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
###end article-title 49
###begin article-title 50
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Insights into cancer from transgenic mouse models.
###end article-title 50

